Bank of New York Mellon
RLYB icon

Bank of New York Mellon’s Rallybio RLYB Stock Holding History

Bank of New York Mellon’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,290
Closed -$167K – 4240
2024
Q1 		$167K Buy
11,290
+5
+0% +$70 ﹤0.01% 3975
2023
Q4 		$216K Sell
11,285
-51
-0.4% -$1.25K ﹤0.01% 3928
2023
Q3 		$306K Sell
11,336
-2
-0% -$87 ﹤0.01% 3790
2023
Q2 		$513K Buy
11,338
+4,921
+77% +$241K ﹤0.01% 3580
2023
Q1 		$293K Sell
6,417
-51
-0.8% -$2.63K ﹤0.01% 3750
2022
Q4 		$340K Buy
6,468
+1,262
+24% +$74.5K ﹤0.01% 3744
2022
Q3 		$603K Sell
5,206
-125
-2% -$11.1K ﹤0.01% 3472
2022
Q2 		$322K Buy
5,331
+120
+2% +$9.02K ﹤0.01% 3838
2022
Q1 		$291K Buy
5,211
+3,089
+146% +$256K ﹤0.01% 4030
2021
Q4 		$162K Buy
2,122
+643
+43% +$74.8K ﹤0.01% 4332
2021
Q3 		$208K Buy
+1,479
New +$173K ﹤0.01% 4202

Other funds holding RLYB

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $127M AUM 217.49% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon's RLYB Position: Q2 2024 in Review

Bank of New York Mellon sold out of Rallybio (RLYB) in Q2 2024, closing a stake of 11,290 shares — an estimated $167K sold.

Bank of New York Mellon first reported a position in RLYB in Q3 2021 and held it in 11 quarters. The position peaked at $603K in Q3 2022. 66 funds tracked by Wall St. Rank hold RLYB as of Q2 2024.

  • Bank of New York Mellon reported no remaining Rallybio position as of Q2 2024 after selling out during the quarter.
  • Bank of New York Mellon sold 11,290 Rallybio shares in Q2 2024, an estimated $167K.
  • Bank of New York Mellon first reported a position in Rallybio in Q3 2021 and held it in 11 quarters.
  • Bank of New York Mellon's Rallybio position peaked at $603K in Q3 2022.
  • 66 funds tracked by Wall St. Rank held Rallybio as of Q2 2024.

Based on Bank of New York Mellon's 13F filing for Q2 2024, filed 25 Jul 2024.